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Abstract
Background: Due to the rapid data accumulation on pathogenesis and progression of chronic
inflammation, there is an increasing demand for approaches to analyse the underlying regulatory
networks. For example, rheumatoid arthritis (RA) is a chronic inflammatory disease, characterised
by joint destruction and perpetuated by activated synovial fibroblasts (SFB). These abnormally
express and/or secrete pro-inflammatory cytokines, collagens causing joint fibrosis, or tissue-
degrading enzymes resulting in destruction of the extra-cellular matrix (ECM).
We applied three methods to analyse ECM regulation: data discretisation to filter out noise and to
reduce complexity, Boolean network construction to implement logic relationships, and formal
concept analysis (FCA) for the formation of minimal, but complete rule sets from the data.
Results: First, we extracted literature information to develop an interaction network containing
18 genes representing ECM formation and destruction. Subsequently, we constructed an
asynchronous Boolean network with biologically plausible time intervals for mRNA and protein
production, secretion, and inactivation. Experimental gene expression data was obtained from SFB
stimulated by TGF1 or by TNF and discretised thereafter. The Boolean functions of the initial
network were improved iteratively by the comparison of the simulation runs to the experimental
data and by exploitation of expert knowledge. This resulted in adapted networks for both cytokine
stimulation conditions.
The simulations were further analysed by the attribute exploration algorithm of FCA, integrating
the observed time series in a fine-tuned and automated manner. The resulting temporal rules
yielded new contributions to controversially discussed aspects of fibroblast biology (e.g.,
considerable expression of TNF and MMP9 by fibroblasts stimulation) and corroborated previously
known facts (e.g., co-expression of collagens and MMPs after TNF stimulation), but also revealed
some discrepancies to literature knowledge (e.g., MMP1 expression in the absence of FOS).
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Conclusion:  The newly developed method successfully and iteratively integrated expert
knowledge at different steps, resulting in a promising solution for the in-depth understanding of
regulatory pathways in disease dynamics. The knowledge base containing all the temporal rules may
be queried to predict the functional consequences of observed or hypothetical gene expression
disturbances. Furthermore, new hypotheses about gene relations were derived which await further
experimental validation.
Background
Rheumatoid arthritis (RA) is characterised by chronic
inflammation and destruction of multiple joints perpetu-
ated by the synovial membrane (SM). A major compo-
nent of the inflamed SM (also called pannus tissue) are
activated, semi-transformed synovial fibroblasts (SFB) [1-
7]. In normal joints, SFB show a balanced expression of
proteins, regulating the formation and degradation of the
extracellular matrix (ECM). In RA, however, SFB are
known for predominant expression and secretion of pro-
inflammatory cytokines and tissue-degrading enzymes
[4,5], thus maintaining joint inflammation, degradation
of ECM components, and invasion of cartilage and bone.
In addition, fibrosis of the affected joints is also driven by
SFB, which express enhanced amounts of ECM compo-
nents such as collagens [8].
Central transcription factors (TFs) involved as key players
in RA pathogenesis [9,10] and in the activation of SFB in
RA patients are AP-1, NF-B, Ets-1, and SMADs [9,11-13].
These TFs show binding activity for their cognate recogni-
tion sites in the promoters of inflammation-related
cytokines (e.g., TNF, IL1, IL6; [1]) and matrix-degrad-
ing target genes [9,10,14-17], e.g., collagenase (MMP-1
[1]) and stromelysin1 (MMP-3 [16]). The latter two show
high expression levels in RA [18-20] and contributes to
tissue degradation [21] by destruction of ECM compo-
nents, including aggrecan or collagen types IV, X, and XI
[22,23].
Due to the rapid accumulation of data about biological
processes and molecular interrelationships, there is an
increasing demand for approaches to analyse the underly-
ing regulatory networks. For instance, a recent analysis of
the mRNA expression profiles in synovial tissue from RA
patients revealed inter-individual and gene-specific vari-
ances [24]. The underlying mechanisms for such complex
behaviour are not understood so far. Mathematical and
computational models may assist biologists in further
research activities by generating predictions and hypothe-
ses that can be experimentally tested. Network models,
generated on the basis of extracted information and/or
experimental data, will considerably facilitate the analysis
of interactions among different key molecules and pro-
vide new insights into complex biological pathways and
interactions (for an overview of methods see [25] and
[26]). This is of particular importance in the context of
rheumatic diseases and cartilage/bone metabolism, since
the development of new and/or adapted molecular thera-
pies depends on the understanding of superordinate path-
way interrelationships in the pro-inflammatory micro-
environment of the joint [4].
Therefore, we developed a method for simulating the tem-
poral behaviour of regulatory and signalling networks. It
was used to create a gene regulatory network emulating
ECM formation and destruction, based on literature infor-
mation about SFB on the one hand and on experimental
data on the other, which we obtained from TGF1 or
TNF stimulated SFB.
The final simulations were analysed by the attribute
exploration algorithm of formal concept analysis (FCA), a
mathematical discipline that has multiple applications in
various domains such as knowledge representation, data
mining, semantic web, or software engineering. First FCA
approaches related to the analysis of gene expression data
have been published (for example [27,28]). Using our
method, the simulation results and the observed time
series were further integrated in a fine-tuned and auto-
mated manner resulting in sets of rules that determine sys-
tem dynamics.
Corresponding to the discrete approach of FCA, we
applied Boolean network architecture for modelling.
Boolean network models, first proposed by Kauffman et
al. [29], use binary variables that define the expression of
a gene i, represented by a network node, as on or off
(active or inactive, i.e., expression signal present or
absent). In biology, this concept is reflected by distinct
expression thresholds which must be exceeded by each
individual gene to initiate their cellular effects, including
disease initiation and progression [30]. Boolean networks
are dynamic models and thus, they require time-series
data as input ("reverse engineering") and generate such
data as output ("simulation"). They can be represented as
directed graphs, with the nodes labelled by Boolean func-
tions. Boolean networks are widely used in molecular
biology for logical analysis and simulation of medium or
large scale networks [31,32]. For example, Kervizic et al.
developed a method for the cholesterol regulatory path-
way in 33 species which eliminates spurious cycles in aBMC Systems Biology 2009, 3:77 http://www.biomedcentral.com/1752-0509/3/77
Page 3 of 19
(page number not for citation purposes)
synchronous Boolean network model [33]. Sets of
Boolean rules are also applied as so-called knowledge
bases in decision support or expert systems.
For our analysis we used a collection of 18 genes, which
can be classified into five functional groups, sufficient to
create a self-contained regulatory network of ECM main-
tenance: (1) structural proteins which are the target mole-
cules (i.e., the collagen I-forming subunits COL1A1 and
COL1A2); (2) enzymes degrading them (i.e., the matrix
metalloproteinases MMP1, -3, -9, and -13); (3) molecules
that inhibit these proteases (tissue inhibitor of metallo-
proteinases TIMP1); (4) TFs (i.e., ETS1, FOS, JUN, JUNB,
JUND,  NKFB1) and modulators acting as TFs (i.e.,
SMAD3, SMAD4, SMAD7) which are regulated by (5) the
external signalling molecules TNF ( TNF) and TGF1
(TGFB1). These genes (Table 1) are known to be expressed
by SFB, except for TNF and MMP9, for which the expres-
sion is still under question (see below).
Results and discussion
Creating a regulatory network by literature extraction
The available literature was screened for genes and pro-
teins involved in ECM maintenance and expressed in the
lining layer SFB of the SM. In order to derive a regulatory
network, we comprehensively collected literature knowl-
edge related to the formation and degradation of ECM in
human fibroblasts and analysed it manually. We chose
collagen type I, which is formed by the COL1A1  and
COL1A2 gene products, as a connective tissue representa-
tive, several MMPs as ECM-degrading enzymes, their
inhibitors, and TFs regulating them. Finally, we selected
18 genes (Table 1) and the literature was screened again
for gene regulatory relations and interactions connecting
them (see additional file 1 for a complete list). Some con-
tradictory literature findings were resolved manually (see
section Boolean functions adapted to the data).
The resulting regulatory network is almost closed and rep-
resents the most important ECM network functions. Here,
we imply that the receptors for the external signalling
molecules are always available and functional in SFB.
Note, that TGF1 (TGFB1) and TNF (TNF) are the only
entities playing a dual role as both external signal mole-
cules and target genes because of their introduction into
the simulation as starting effectors.
It turned out that the knowledge about gene regulatory
events is limited and that, to the best of our knowledge,
the regulation of SMAD and SMAD expression has not
been fully characterised so far. The SMAD gene products
seem to be available in sufficient amounts and we were
unable to find reports about their regulated expression. In
addition, not all influences of TGF1 and TNF on gene
expression could be described as direct effects of transcrip-
tion factors at the mRNA level because the important
SMAD family members act as regulators on the protein-
protein interaction level. All influences were included in
Table 1: List of genes used in this analysis.
Name Protein name Protein class Main function
COL1A1 Type I collagen alpha 1 chain Structural component Cartilage and connective tissue collagen
COL1A2 Type I collagen alpha 2 chain Structural component Cartilage and connective tissue collagen
MMP1 Matrix metalloprotease 1 (interstitial collagenase) Protease Cleavage of collagen I, II, and III
MMP3 Matrix metalloprotease 3 (stromelysin 1) Protease ECM component degradation
MMP9 Matrix metalloprotease 9 (gelatinase B) Protease Cleavage of collagen IV and V
MMP13 Matrix metalloprotease 13 (collagenase 3) Protease Cleavage of collagen I and III
TIMP1 Tissue inhibitor of metalloprotease 1 
(collagenase inhibitor)
Protease inhibitor Inhibits matrix metalloproteases, and others
ETS1 v-ets erythroblastosis virus E26 oncogene homolog 
1
Transcription factor Erythroblast and fibroblast transformation
FOS v-fos FBJ murine osteosarcoma viral oncogene 
homolog
Component of AP-1 Regulator of proliferation, differentiation, and 
transformation
JUN v-jun avian sarcoma virus 17 oncogene homolog Component of AP-1 Regulator of proliferation, differentiation, and 
transformation
JUNB jun B proto-oncogene Component of AP-1 Regulator of proliferation, differentiation, and 
transformation
JUND jun D proto-oncogene Component of AP-1 Regulator of proliferation, differentiation, and 
transformation
NKFB1 Subunit 1 of nuclear factor kappa-B Component of NF-B Involved in many biological processes
SMAD3 SMA- and MAD-related protein 3 Transcriptional modulator Mediator of signal transduction by TGF1 (RSMAD)
SMAD4 SMA- and MAD-related protein 4 Transcriptional modulator Mediator of signal transduction by TGF1 
(CoSMAD)
SMAD7 SMA- and MAD-related protein 7 Transcriptional modulator Antagonist of signalling by TGF1 (ISMAD)
TNF Tumour necrosis factor alpha Cytokine Proinflammatory role
TGFB1 Transforming growth factor beta 1 Growth factor Involved in proliferation and differentiationBMC Systems Biology 2009, 3:77 http://www.biomedcentral.com/1752-0509/3/77
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the network at this point to avoid premature loss of infor-
mation.
Although many TFs such as AP-1 are also regulated at the
protein level (e.g., by phosphorylation), those effects can
be reflected simplistically by regulatory processes at the
transcriptional level. However, activating SMADs as
SMAD3 and SMAD4 are also regulated by inhibitory
members of the SMAD family (SMAD6 and SMAD7),
which may counteract transcriptional activation and add
an extra level of complexity [34]. Therefore, SMAD7 was
introduced into the network as a TGF1-dependent
repressor of SMAD-dependent transcription.
In the case of SMAD3, we decided to subsume its influ-
ence under the SMAD4 effects because both are described
to have nearly identical effects and act in concert. Moreo-
ver, we could not find well-defined information about
SMAD3 regulation. Hence, we added an inducing influ-
ence of SMAD4 on MMP13 (at present only known for
SMAD3) for keeping all the SMAD effects in the network.
The subunits of the homo- or heterodimer TF AP-1, i.e.,
Jun, JunB, JunD, and Fos (JUN, JUNB, JUND, FOS), deter-
mine its different regulatory activities (for AP-1 compo-
nents see [35] and references therein). Therefore, we
decided to disassemble the transcriptional active entity
AP-1 into its subunits. In contrast, for the dimeric TF NF-
B, which composed of the gene products of NFKB1,
NFKB2, RELA, RELB, and/or REL [36], we selected NFKB1
as the representative gene with respect to our signalling
framework. All the genes and their interrelations were
transferred into the program Cytoscape [37] to visualise
our network containing 19 nodes and 79 edges, respec-
tively, as shown in Figure 1. Detailed network examina-
tion is available through the network description files
(additional files 2 and 3), also providing external links to
GenBank, Uniprot, and PubMed for all edges and nodes.
Available tools for automatic text mining decide schemat-
ically, e.g., by pre-built rules like co-occurrence of gene
names and interaction verbs or pattern matching, whereas
a human expert is able to integrate unanticipated types of
information and to decide whether the paper confirms the
investigated situation. However, we used the tools Biblio-
sphere [38] and Pathway Studio [39] in order to verify
completeness and consistency of the assembled network
(data not shown).
Boolean functions
Due to its capability for displaying dynamic dependencies
between individual parameters, a Boolean network is
more specific than the graphical network in Figure 1,
which summarises isolated literature facts. In order to
decide about the connectives OR/AND, which represent
causally determined relations between different genes,
cellular signalling processes were also considered.
In the case of a known transcriptional activation of any
gene by the stimuli TNF or TGF1 via a specific TF, this
activation was represented in the network using the term
GENE.out = STIMULUS AND TF. Without such evi-
dence, these influences were connected by GENE.out =
STIMULUS OR TF. Since it is well known that the so-
called SMAD pathway is activated by TGF1 but not influ-
enced by TNF [40], we used the AND connection for
SMAD3/4 and TGF1, even if there was no explicit litera-
ture evidence for an impact of TGF1 onto the respective
gene.
Another example for setting up the functions is the inte-
gration of: (i) the known auto-regulatory transcriptional
activation of JUN by TNF via JUN, and (ii) the activation
of JUN via SMAD4 (TNF – independent) into the single
Boolean function 5 (compare Table 2 with Tables 3 and
4): JUN.out = (TNF AND JUN) OR (TGFB1 AND
SMAD4). Based on the illustrated principles, the Boolean
functions characterising formation and remodelling of
the ECM were generated (Table 2).
Gene expression time courses following TGF1 and TNF 
stimulation
We analysed gene expression changes of SFB from patients
with RA (3 patients) or OA (3 patients) following TGF1
and TNF stimulation (Table 5). Due to the strong stim-
uli, both groups of cells reacted in an almost identical
way, and we did not differentiate among them. In another
study, for example, OA cells were considered to be a dis-
ease control group [41].
Following pre-processing of the microarray data gained
from U133 Plus 2.0 arrays, we extracted the data for probe
sets related to our genes of interest (see Methods). The
data are available in the GEO database (GSE13837 at
[42]). For the following analyses we excluded values
which exceeded the reliability threshold of p  0.05 for
any patient at any time point (0, 1, 2, 4, 6, and 12 hours).
In Figure 2, some selected examples for the influence of
TGF1 and on gene expression are presented. The time
courses of COL1A1 and JUNB expression are shown to
illustrate the TGF1 response in SFB, and the TNF
response is illustrated by NFKB1 and MMP1 expression.
SMAD7 expression data are also included for both treat-
ments. The data and the respective diagrams for all genes
and both treatments can be found in additional file 4.
For comparative purposes, we also analysed public data
from the GEO database, first, TGF1 treated murine
embryonic fibroblasts (GSE1742) and second, TNF
stimulation of endothelial cells (HeLa, GSE2624). Fol-BMC Systems Biology 2009, 3:77 http://www.biomedcentral.com/1752-0509/3/77
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lowing prolonged TGF1 treatment in murine cells,
COL1A2,  JUN, and TIMP1  gene expression increased,
whereas FOS decreased. In contrast, FOS, JUN, and JUNB
expression in HeLa cells rapidly increased following TNF
stimulation. Unfortunately, no data about the protease
genes were available in this dataset (additional file 5).
Even though cell type, experimental design and duration
of treatment differ from our experiments, they reflect the
two general trends: a positive effect on ECM formation by
TGF1 and a degradative influence on ECM by TNF
(mediated at least in part by FOS and JUN), which is con-
sistent with our data. However, the evaluation of the com-
plete data sets revealed discrepancies between the
expected expression profile of individual genes and their
time courses following stimulation in the experiment.
Data discretisation
We developed a data discretisation method which appro-
priately captures biologically relevant differences in gene
expression levels. The individual time profiles for each
gene were separately discretised to the values 0or 1 by k-
means clustering [43], a method which is often applied
for gene expression time series. No improvements were
observed when applying Ward's hierarchical clustering
[44] or single linkage clustering as proposed in [45] (data
not shown). We introduced several supplementary criteria
(see Methods), e.g., the values of a time series were all dis-
cretised to the constant value 0 or 1, if the differences of
all log2 values (fold-changes) were less than 1 [46]. For
the discretised data see additional file 6.
Boolean functions adapted to the data
Simulations were generated using an asynchronous
update scheme, assuming time intervals – approximately
equal to 1 h time steps – as follows: transcription 1
(NFKB1: 2), translation: 1, RNA lifespan: 1, and protein
lifespan:  2. The Boolean functions generated the tran-
scriptional states according to the functional influence of
proteins (stimuli or TF); translation and mRNA/protein
degradation were computed from this output state accord-
ing to the predefined intervals (see Principles of simula-
tion in Methods section).
Overview of the ECM network in hierarchical order Figure 1
Overview of the ECM network in hierarchical order. Regulatory effects via TF s are shown as continuous lines, others 
as indirect effects as dashed lines. Inhibition is marked by a red T-arrow, induction is illustrated by black arrows. The external 
signals TGF1 and TNF are shown as light grey circles, the internal SMAD signalling molecules as dark grey squares, TFs are 
depicted as black (AP-1 components) or white squares, and the target genes are shown as white octagons. This picture was 
generated using Cytoscape 2.6.0.BMC Systems Biology 2009, 3:77 http://www.biomedcentral.com/1752-0509/3/77
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As starting conditions of the simulations we chose the dis-
cretised initial states derived from our experimental data.
An additional initial state was introduced in which solely
the transcription factors were set to on, which enables the
model system to respond to the external stimulators TNF
or TGF1 immediately. The simulations were performed
over twelve time steps; however, we did not aim at an
exact correspondence to the experimental observation
time of twelve hours, but tried to adjust the simulated
time courses to qualitative features such as early, interme-
diate or late up-regulation. Improving the Boolean func-
tions accordingly, the initially applied literature-based
information was completed by: (i) valid and specific
experimental information; (ii) knowledge and experience
of biological experts; and (iii) in some cases, a more
focused and precise literature query (Tables 3 and 4). For
a comparison of the discretised observed time series and
the final simulations see the additional files 6 and 7. We
developed several biologically interesting and plausible
data-independent hypotheses, for example, we modelled
the regulation of SMAD3/SMAD4 effects by a protein-pro-
tein interaction with SMAD7.
The resulting optimised Boolean network with the revised
Boolean functions (Tables 3 and 4) represents an
enhanced ECM model, roughly matching the given bio-
logical conditions and extensively exceeding the present
possibilities of automatic methods such as text mining,
symbolic computation or machine learning. Considering
the additional information available, we accepted these
biologically reasonable changes:
1. In the case of TNF (or TGF1) stimulation, the pro-
duction and secretion of TGF1 (or TGF) by SFB should
not contradict the influence of the abundant stimulating
protein TNF (or TNF1). In these cases (e.g., for the
COL1A1.out function in Table 4, and for the MMP1.out
function in Table 3) we removed TGFB1 (TNF) AND
(...) from the Boolean function term. This adjustment
did not always change the simulation result, since, for
Table 2: Boolean functions based on literature information.
1 COL1A1.out = (TGFB1 OR FOS OR JUN) AND NOT (TNF AND (NFKB1 OR ETS1))
2 COL1A2.out = ((TGFB1 AND JUND) OR JUN) AND NOT (TNF AND (NFKB1 OR ETS1))
3 ETS1.out = ((TNF AND (ETS1 OR JUN)) OR FOS) AND NOT SMAD4
4 FOS.out = (TGFB1 OR (TNF AND NFKB1)) AND NOT (JUN AND FOS)
5 JUN.out = (TNF AND JUN) OR SMAD4
6 JUNB.out = (TGFB1 AND NFKB1 AND SMAD4) OR (TNF AND NFKB1)
7 JUND.out = (TGFB1 OR TNF) AND JUND AND NOT FOS
8 MMP1.out = ((TNF AND (ETS1 OR NFKB1)) OR FOS OR JUND) AND NOT TGFB1
9 MMP3.out = (TNF AND (ETS1 OR JUN OR NFKB1)) OR FOS OR TGFB1
10 MMP9.out = TNF AND (ETS1 OR NFKB1)
11 MMP13.out = (TNF AND (JUN OR NFKB1)) OR FOS OR (TGFB1 AND SMAD4)
12 NFKB1.out = (TNF AND (ETS1 OR NFKB1)) OR TGFB1
13 SMAD4.out = TGFB1
14 SMAD7.out = ((TGFB1 AND SMAD4) OR FOS OR JUN) AND NOT (TNF AND NFKB1)
15 TIMP1.out = (TGFB1 AND SMAD4) OR (TNF AND (JUN OR JUNB OR JUND OR NFKB1)) OR FOS
16 TGFB1.out = FOS OR JUND
17 TNF.out = TNF AND (ETS1 OR JUN OR NFKB1)BMC Systems Biology 2009, 3:77 http://www.biomedcentral.com/1752-0509/3/77
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example, TNF was always off following TGF1 stimula-
tion (numbers of the Boolean functions (BF) affected: 1,
2, 3, 8, 9, 11, 12, and 14).
2. Down-regulation of gene expression is an essential bio-
logical principle. For that reason we had to introduce a
time-limited inactivation mechanism which could not be
derived from the literature because information regarding
down-regulatory mechanisms is very restricted. Moreover,
complex and variable mechanisms were hard to model,
e.g., JUN down-regulation which is driven by: (i) inactiva-
tion of the TF protein itself; (ii) a general shift in the com-
position of the TF AP-1, resulting in a reduced amount of
TF enhancing JUN transcription; and (iii) binding/inacti-
vation of JUN by other proteins. Therefore, a time-limited
mRNA inactivation was introduced for JUN, JUNB, FOS,
and ETS1. Accordingly, an inactivating rule was created: if
these TFs are expressed at t> 0, they will be set to off at
t+3 and afterwards (no. of BF affected: 18). In addition,
at that step we included an inhibition of TGFB1/SMAD4
signalling-based target gene expression by integrating a
SMAD4-inhibiting signal (i.e., SMAD7, included as AND
NOT SMAD7) guaranteeing the subsequent inactivation of
TGF1-related gene expression (BF affected: 3, 5, 6, 14,
and 15). JUND is constitutively expressed at an intermedi-
ate level, which is consistent with GEO (GSE1742 and
GSE2624) and our own data, as well as with the literature
[47]. For NFKB1 transcription, an inhibitory effect was
not implemented, since the activity of NF-B at the pro-
tein level is controlled by interaction with several IKB pro-
Table 3: Revised Boolean functions for the simulation of TGF1 stimulation. 
1 COL1A1.out = TGFB1 OR FOS OR JUN *
2 COL1A2.out = (TGFB1 AND JUND) OR JUN *
3 ETS1.out = FOS AND NOT (TGFB1 AND SMAD4 AND NOT SMAD7) *
4 FOS.out = (TGFB1 OR (TNF AND NFKB1)) AND NOT (JUN AND FOS)
5 JUN.out = (TNF AND JUN) OR (TGFB1 AND SMAD4 AND NOT SMAD7)
6 JUNB.out = (TGFB1 AND NFKB1 AND SMAD4 AND NOT SMAD7) OR (TNF AND NFKB1)
7 JUND.out = TGFB1 OR TNF OR (JUND AND NOT FOS)
8 MMP1.out = JUND AND NOT (TGFB1 AND FOS)*
9 MMP3.out = (TNF AND ((ETS1 AND NFKB1) OR JUN)) OR FOS
10 MMP9.out = TNF AND ETS1 AND NFKB1
11 MMP13.out = (TNF AND (JUN OR NFKB1)) OR FOS
12 NFKB1.out = TNF OR ETS1 OR NFKB1 *
13 SMAD4.out = TGFB1 *
14 SMAD7.out = (TGFB1 AND SMAD4 AND NOT SMAD7) OR FOS OR JUN *
15 TIMP1.out = (TGFB1 AND SMAD4 AND NOT SMAD7) OR (TNF AND (JUN OR JUNB OR JUND OR NFKB1)) OR 
FOS
16 TGFB1.out = FOS OR JUND
17 TNF.out = TNF AND ((ETS1 AND NFKB1) OR JUN)
18 Inactivation rule If the transcription factors ETS1, FOS, JUN or JUNB are expressed at t > 0, they will be down- regulated at t+3 and 
afterwards.
Rows marked by an asterisk indicate differences of the functions for TGF1 and TNF stimulation, changes to Table 2 are italicised and printed in 
bold. Function numbers in bold indicate omitted (1, 2, 3, 8, 9, 11, 12, 14) or inserted (18) terms.BMC Systems Biology 2009, 3:77 http://www.biomedcentral.com/1752-0509/3/77
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teins [48] which were not included in our ECM network
model.
3. SMAD4 induction is not dependent on TGF1 stimula-
tion, because it is constitutively expressed (i.e., always
TRUE, BF affected: 13). However, without TGF1-medi-
ated phosphorylation, SMAD4 is not activated at the pro-
tein level and shows no transcriptional activity, even
though constitutively expressed. Therefore, we amended
the term SMAD4 to TGF AND SMAD4 in order to represent
the necessity of TGF1 for SMAD4 activation (BF affected:
3, 5).
4. We considered the relation ETS1 AND NFKB1 for the
target genes [49] instead of assuming alternative pathways
by ETS1 OR NFKB1 because regulation by NF-B seems
to be dependent on ETS1, and the MMPs, for example,
require both factors [50] (BF for TGF stimulation affected:
9, 10, and 17, Table 3; BF for TNF stimulation affected: 2,
8, 9, 10, and 17, Table 4).
5. Since the inhibition of JUND expression by FOS is only
observed in the case of a concomitant JUND-based posi-
tive feedback, the inhibitory effect of FOS has been
restricted to this case [51] (BF affected: 7).
6. Since a TF should not necessarily be required for its own
expression (positive feedback), in the case of JUND (and
also NFKB1) the AND connection was changed to OR. The
revision of this function prevents the absence of JUND
Table 4: Revised Boolean functions for the simulation of TGF stimulation. 
1 COL1A1.out = (FOS OR JUN) AND NOT (TNF AND ETS1 AND NFKB1) *
2 COL1A2.out = JUN AND NOT (TNF AND ETS1 AND NFKB1) *
3 ETS1.out = (TNF AND (ETS1 OR JUN)) OR FOS *
4 FOS.out = (TGFB1 OR (TNF AND NFKB1)) AND NOT (JUN AND FOS)
5 JUN.out = (TNF AND JUN) OR (TGFB1 AND SMAD4 AND NOT SMAD7)
6 JUNB.out = (TGFB1 AND NFKB1 AND SMAD4 AND NOT SMAD7) OR (TNF AND NFKB1)
7 JUND.out = TGFB1 OR TNF OR (JUND AND NOT FOS)
8 MMP1.out = (TNF AND ETS1 AND NFKB1) OR FOS OR JUND *
9 MMP3.out = (TNF AND ((ETS1 AND NFKB1) OR JUN)) OR FOS
10 MMP9.out = TNF AND ETS1 AND NFKB1
11 MMP13.out = (TNF AND (JUN OR NFKB1)) OR FOS
12 NFKB1.out = TNF AND (ETS1 OR NFKB1) *
13 SMAD4.out = TRUE *
14 SMAD7.out = (FOS OR JUN) AND NOT (TNF AND NFKB1) *
15 TIMP1.out = (TGFB1 AND SMAD4 AND NOT SMAD7) OR (TNF AND (JUN OR JUNB OR JUND OR NFKB1)) OR 
FOS
16 TGFB1.out = FOS OR JUND
17 TNF.out = TNF AND ((ETS1 AND NFKB1) OR JUN)
18 Inactivation rule If the transcription factors ETS1, FOS, JUN or JUNB are expressed at t > 0, they will be down-regulated at t+3 and 
afterwards.
Rows marked by an asterisk indicate differences of the functions for TGF1 and TNF stimulation. changes to Table 2 are italicised and printed in 
bold. Function numbers in bold indicate omitted (1, 2, 8, 9, 11, 12, 13, 14) or inserted (18) terms.BMC Systems Biology 2009, 3:77 http://www.biomedcentral.com/1752-0509/3/77
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expression following TGF1 stimulation (BF affected: 7,
12).
7. Concerning the regulation of MMP1 expression by FOS,
there were contradictory findings in the literature [52,53].
We decided for an inhibitory influence of FOS following
TGF1 stimulation, because otherwise MMP1 would have
been permanently down-regulated by TGF1 during the
simulation (BF affected: 8, Table 3).
8. The Boolean function MMP3.out = (...) OR
TGFB1 was in obvious contradiction to the data of the
present study, thus, the term OR TGFB1 was deleted. The
same was done for the MMP13 function (BF affected: 9,
11).
9. In the case of NFKB1, the absence of TNF stimulation
had no decisive influence (NFKB1 was not always off).
For that reason, we changed NFKB1.out = TNF AND
(ETS1 OR NFKB1) to NFKB1.out = TNF OR ETS1
OR NFKB1 (BF affected: 12, Table 3).
10. However, concerning the expression of TNF itself, the
necessity of a positive feedback could explain its complete
absence following TGF1 stimulation. On the other hand,
TNF was expressed at some time points following com-
monly assumed that fibroblasts do not express TNF (BF
not changed: 17).
In summary, we adjusted the set of BF obtained by adap-
tation to the gene expression data measured under two
experimental conditions (TNF and TGF1 stimulation),
in order to create an appropriate set of BF representing the
existing knowledge about naturally occurring interrela-
tionships as accurately as possible.
Computing temporal rules by attribute exploration
For each stimulus, the observed and the (final) simulated
time series were translated and merged into a single for-
mal context, the basic tabular data structures of FCA (see
section Creation of a temporal rule knowledge base in the
Methods section). States are defined by the value on or
off for each gene, and transitions were computed by link-
ing an occurring input state to an arbitrary future (output)
state of the simulation or observation. The set of all these
transitions (formal context, compare Table 6) was ana-
lysed by the automatic, noninteractive version of the
attribute exploration algorithm, which computes a mini-
Table 5: Clinical characteristics of the patients at the time of synovectomy/sampling.
Rheumatoid Osteoarthritis
Arthritis (RA) (OA)
Patients (n) 33
Sample name RA1, RA2, RA3, OA1, OA2, OA3
Gender (female/male) 3/0 1/2
Age (years ± SEM) 62.4 ± 2.9 58.7 ± 2.0
Disease duration (years ± SEM) 11.5 ± 0.5 4.4 ± 0.6
Rheumatic factor (positive/negative) 3/0 0/3
ESR1 (mm/h ± SEM) 26.7 ± 6.2 20.0 ± 4.0
CRP2 (mg/l ± SEM) 38.1 ± 7.2 13.2 ± 2.9
ARA3 – Criteria for RA (n ± SEM) 6.0 ± 1.1 0.3 ± 0.1
Concomitant MTX4 (n) 1 0
medication NSAIDs5 (n) 3 3
1 Erythrocyte sedimentation rate
2 C-reactive protein, normal range: < 5 mg/l
3 American Rheumatism Association (now: American College of Rheumatology)
4 Methotrexate
5 Non steroidal anti-inflammatory drugsBMC Systems Biology 2009, 3:77 http://www.biomedcentral.com/1752-0509/3/77
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mal and complete knowledge base (stem base), from
which all implications of a given formal context can be
derived [54].
The implications of the stem base are temporal rules
expressing hypotheses about attributes of states (e.g., co-
regulation or mutual exclusion of gene expression) or sys-
tem dynamics, which are supported by pre-existing
knowledge and by the analysed data. Since an implication
holds for the transitions between all temporally related
states, a rule such as GENE1.in.on  GENE2.out.on
means: if gene1 is expressed, gene2 always will be up-reg-
ulated in the future, at all subsequent observation time
points, and simulation steps. Due to this semantics, the
implications neither depend on the correspondence of a
simulation time step to a specific observation interval, nor
on prior knowledge about time periods of direct or indi-
rect transcriptional effects. Within the large knowledge
bases for TNF (8,785 rules) and TGF1 (2,713 rules)
stimulation, the most frequent and simple temporal rules
were considered and analysed for dependencies between
stimuli, induced TFs, and their target genes.
Gene expression time courses following TGF1 or TNF treatment Figure 2
Gene expression time courses following TGF1 or TNF treatment. COL1A1 (A), JUNB (B), and SMAD7 (C) gene 
expression in response to TGF1 treatment (upper row); TNF response (lower row) of NFKB1 (D), MMP1 (E), and SMAD7 
(F). The average time course is shown as light red curve without symbols, the data for individual samples are depicted in other 
colours (OA1: blue, filled symbol; OA2: red, filled symbol; OA3: green, filled symbol; RA1: purple, filled symbol; RA2: blue, 
open symbol; RA3: yellow, open symbol). The time courses and the values calculated from the microarray experiments for all 
analysed genes are included in additional file 4.
Table 6: Example for the observed transition context Kobs. The rows represent the transitions from state n to the state (n+1) of sample 
OA1 following TNF stimulation.
Attribute 
FOS.in JUN.in JUNB.in JUND.in MMP3.in ... FOS.out JUN.out JUNB.out JUND.out MMP3.out ...
Transition 
(s0
in,s1
out) on off off on off ... on on on on on ...
(s0
in,s2
out) on off off on off ... off on on on on ...
(s0
in,s4
out) on off off on off ... off off off on on ...
(s0
in,s12
out) on off off on off ... on off off on on ...
(s1
in,s2
out) on on on on on ... off on on on on ...
... ... ... ... ... ... ... ... ... ... ... ... ...BMC Systems Biology 2009, 3:77 http://www.biomedcentral.com/1752-0509/3/77
Page 11 of 19
(page number not for citation purposes)
Results of the attribute exploration
Stimulation with TNF
Regarding stimulation with TNF, a coordinated down-
regulation with of the two TF SMAD7 (inhibitor of
TGF1/SMAD4 signalling) and ETS1 emerges, as indi-
cated by the rules 33, 114, 135, 144, 157, and 186 (see
additional file 8). For example, rule 186:
                     <90> COL1A1.out.off,
EST1.out.off    SMAD7.out.off                                     
has the meaning: in all simulated and observed states
characterised by the absence of COL1A1 and ETS1,
SMAD7 is also off. <90> stands for the support of the
rule, i.e., the number of transitions (90 out of 294) that
actually have the attributes of the premise. Rules 114, 135,
144, 157, and 186 indicate: if the TNF-dependent genes
are not induced (ETS1 as mediator), then simultaneously
the expression of TGF1-dependent genes is enabled
(SMAD7 is off). This suggests that TNF and TGF1 may
act as antagonists in SFB, as described in [55,56].
The expression of NFKB1, which is also induced by TNF,
proceeds conversely to that of ETS1 and SMAD7 (rules 34,
45, 70, 71, 134, 144, 154, 157, and 173) reflecting the dif-
ferent targets of NF-B and SMAD7. The antagonistic pat-
tern of NFKB1 and SMAD7 appears indirectly in rule 33,
where the two genes show up in the premise of a rule with
high support:
                     <150> (...)
NFKB1.out.on, SMAD7.out.off 
EST1.out.off                   
Regarding this rule, it is interesting that ETS1 always acts
in the same direction as NF-B, according to the network
derived from the literature (Figure 1). In the adapted net-
work (Table 4), we assumed a necessary cooperation (i.e.,
an AND connective) for the positive regulation of ETS1,
MMP1, MMP3, MMP9, and TNF, as well as for the inhibi-
tion of COL1A1 and COL1A2. Thus, rule 33 further sug-
gests that the coordinated action of NF-B and ETS1 is
turned off in states which are characterised by supplemen-
tary conditions as SMAD7.out.off.
The generated rules adequately reflect the major influence
of the TF AP-1 in the system: the expression of prominent
targets, such as COL1A1, MMP1, and MMP3, depends on
JUN (rules 211 and 258) and/or FOS (rule 204), with JUN
as the key player. These rules connect input and output
states and thus their semantics is directly related to
dynamics, as seen in rule 211:
                     <87> TGFB1.in.on,
TIMP1.in.on, ETS1.in.on, JUN.in.on 
MMP1.out.on                   
making this strong statement: if ETS1 and JUN are on,
MMP1 will always be up-regulated in the future (at least
within the time frame of 12 hours).
Sometimes, MMP1 is expressed simultaneously or before
ETS1 and JUN. In the simulation, MMP1 was always on in
the output state and from time point 2 h in the data. An
exception can be found for the experimental results from
OA sample OA3 (Table 5), where MMP1 is off after 12 h.
This is the reason for the computation of the auxiliary
conditions  TGFB1.in.on and TIMP1.in.onin rule
211.
Concerning the regulation of target genes, the expression
of MMP1, MMP3, and MMP13 is co-regulated (rules 35,
63, 82, 86, and 176), while MMP9 is expressed independ-
ently (rules 24 and 35). There is a contradiction between
the simulation and the data: in the observed experimental
time series, MMP13 is always off, whereas the Boolean
network predicts an up-regulation similar to MMP1 and
MMP3. This unexpected absence of predicted MMP13
expression may be an indication for a more complex reg-
ulation of MMP13  transcription, exceeding the already
known regulatory interrelations. Therefore, the MMP13
promoter and further enhancer/repressor sequences
should be targeted for a more pronounced structural and
functional analysis. For MMP9, the simulation and the
experimental data are in good agreement: the gene is off
in most, but not all states. However, since the expression
of MMP9 by (S)FB is discussed controversially in the liter-
ature (see [57] and [58]vs. [59]), the calculated expression
of MMP9 by fibroblasts – at least at a limited number of
time points – supports the majority of studies, reporting
detectable MMP9 mRNA amounts in (S)FB.
Several rules unanimously indicate the co-expression of
the ECM-forming genes COL1A1 and COL1A2 (rules 87,
88, and 95), but contradictory rules occur concerning
their expression profile in comparison to the MMPs.
COL1A1  and  COL1A2  seem to be co-expressed with
MMP1 (rules 90 and 176), for COL1A2, however, a certain
co-expression with MMP9 is calculated as well (rules 76
and 77), which conflicts with the opposing expression of
MMP1 and MMP9 (see above). Therefore, the expression
of collagens does often, but not necessarily always corre-
late with the expression of MMPs. This reflects the imbal-
ance between MMP-dependent destruction and collagen-
driven regeneration/fibrosis of ECM in the joints in
inflammatory RA.BMC Systems Biology 2009, 3:77 http://www.biomedcentral.com/1752-0509/3/77
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The calculated knowledge base also contains a further
unexpected correlation. According to rule 166:
                     <94> FOS.in.off,
TIMP1.in.on, SMAD7.out.off 
TGFB1.in.on,  MMP1.out.on,  TGFB1.out.on                                     
and rule 188, the expression of MMP1  may also be
induced in the absence of FOS (e.g., by JUN-containing
AP-1 complexes), indicating that the regulation of MMP1
does not predominantly depend on FOS as proposed in
the literature [17,60]. This result may point to the influ-
ence of other TFs, e.g., NF-B, ETS1, or AP-1 complexes
containing JUN, which may indeed be able to induce tar-
get gene expression in the absence of FOS.
Stimulation with TGF1
For the stimulation with TGF1, we had a total number of
341 transitions. The SMADs play a major role for the
expression of TGF1-dependent target genes, as reflected
by various classes of rules containing SMAD4 and/or
SMAD7 (see additional file 8). For example, SMAD4 can
be involved in the expression of COL1A1, see rule 15 (and
also rules 21, 26, and 30):
                    <239> ETS1.out.off
 SMAD4.in.on, COL1A1.out.on,
SMAD4.out.on                   
This also suggests an antagonistic behaviour of ETS1 and
SMAD4: if ETS1 was off, then SMAD4 was on, as well as
in all previous states. Rules 52 and 57 suggest a depend-
ency of MMP1 on SMAD4. However, this seems to be one
amongst many other influences (or could be a non-influ-
encing coincidence), since SMAD4 was permanently on
during simulation and experimental stimulation with
TGF1 (exception: sample RA3 at time point 2 h).
The expression of MMP9 is neither induced by SMAD4
(rules 7, 24, and 41) nor by any other TF, indicating that
MMP9 is not influenced by TGF1. The fact that TGF1
obviously does not induce MMP9  (but other MMPs)
agrees with findings reported previously [59] and repre-
sents a clear contrast to the MMP expression profiles fol-
lowing TNF stimulation.
A further case of an antagonistic expression pattern was
calculated for MMPs and COL1A1 (rules 21, 30, 36, 41,
54, and 60), for example, in rule 54:
                     <170> SMAD4.in.on,
MMP3.out.off, MMP9.out.off,
MMP13.out.off,  ...    COL1A1.out.on                                     
Antagonistic expression profiles also can be observed for
SMAD4 and other TFs, e.g., JUN and JUNB (rules 12, 39)
or ETS1 (rule 15, see above). The variety of TF combina-
tions found, even following the same stimulus, exceeds
the possibilities of conventional TF studies because stim-
ulation experiments are generally restricted to a selected
set of readout parameters (e.g., the expression of single
TFs or target genes) which are not able to reflect the mul-
tiplicity of different effects in the cell.
Following stimulation with TGF1, interestingly COL1A2
appears to be constitutively expressed since its status is
always calculated as on (rule 1). Therefore, for the forma-
tion of collagen I, which contains COL1A1 and COL1A2
chains, COL1A1 expression seems to be the critical switch.
TGF1 versus TNF effects
The calculated results impressively illustrate that TGF1
and TNF stimulation are mediated via separate signal
transduction pathways, leading to the expression and acti-
vation of different TFs. In general, ETS1 and NFKB1 are
induced predominantly by TNF, whereas SMAD expres-
sion depends on TGF1 (represented by differential
expression profiles of ETS1 and SMAD4). JUN and FOS,
however, strikingly respond to both stimuli. This defined
pattern results in the expression of target genes with
opposing roles. TGF1 positively regulates the enhanced
formation of ECM components, whereas TNF is strongly
involved in the expression of ECM-degrading enzymes.
This was the main reason for a discriminative revision of
the BF for TNF and TGF1 (Tables 3 and 4). Six BF were
found to be differently adjusted (BF 1, 2, 3, 8, 12, and 14),
which concern either the key players for ECM destruction
(MMP1; BF 8), ECM formation (COL1A1 and COL1A2;
BF 1 and 2) or important regulatory genes (ETS1, NFKB1,
SMAD7). This may indicate that the differential effects on
ECM induced by TNF or TGF1 are mainly mediated via
ETS1 (BF3), NFKB1 (BF 12, especially in the TNF path-
way), or SMAD7 (BF 14, especially in the TGF1 pathway)
identifying ETS1- and NFKB1-associated pathways as the
major TNF-induced pro-inflammatory/pro-destructive
signalling modules in rheumatic diseases, whereas
TGF1-driven and SMAD7-related signalling appear to be
prominently involved in fibrosis.
Querying the knowledge base
The minimal rule set gave many new insights, and further
queries can be addressed by accessing the TNF and
TGF1 knowledge bases in one of two ways: (i) the Excel
file containing the transition rules for structured searches
within the rule sets (see additional file 8 containing the
top 500 transition rules, additional files 9 and 10 for com-
plete lists); and (ii) the stem base in PROLOG format for
queries concerning logically implied rules (additional
files 11 and 12).BMC Systems Biology 2009, 3:77 http://www.biomedcentral.com/1752-0509/3/77
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Conclusion
The analyses in the present study were based on literature
data valid for healthy human SFB. These findings were
fine-tuned and adapted to gene expression time course
data triggered by TGF1 and TNF in SFB from RA and OA
patients. Both the assembly of previous knowledge and
the adaptation of the Boolean functions gave detailed
insight into disease-related regulatory processes. To the
best of our knowledge, this is the first dynamical model of
ECM formation and degradation by human SFB.
One of the strengths of the FCA method applied here is its
ability to give a complete, but minimal representation of
observed or simulated data. This complete overview of
temporal rules enabled us to find new relationships. The
most unexpected result is the expression of TNF at some
time points following TNF stimulation, whereas it is
commonly assumed that SFB do not express TNF [61-64].
Similarly, our experimental data as well as our simulation
results support MMP9 expression in SFB thus corroborat-
ing the majority of the literature regarding expression of
this protease [57,58]. Here, it is important to note that a
contamination of our SFB population with macrophages
(potentially contributing to MMP9 production) can be
excluded due to the SFB isolation protocol, resulting in a
pure SFB population [65]. We also found that MMP1 was
induced in the absence of FOS after TNF stimulation,
whereas  MMP13  was not expressed despite of reports
about its induction by NF-B, JUN, or FOS. These facts
indicate that the regulation of MMP and TNF expression
may be more diverse than presently known and that it still
represents a relevant research target to elucidate the role of
SFB in the pathophysiology of rheumatic diseases.
Concerning the formation of collagen type I fibres by
COL1A1 and COL1A2 proteins following the stimulation
with TGF1, a constitutive expression of COL1A2 was cal-
culated. Based on these data, COL1A1 has to be regarded
as the critical switch for the formation of collagen I. In
contrast, the corresponding literature generally postulates
a co-regulation of both genes, due to similarities in their
promoters [66,67]. This difference suggests that the regu-
lation of COL1A1 and COL1A2 may not have been fully
elucidated so far possibly pointing at COL1A1 as a more
promising target for the exploration of fibrosis.
Our analyses also show that TNF-induced signalling pre-
dominantly results in the activation of ETS1 and NFKB1,
whereas TGF1-related signal transduction is ultimately
mediated via proteins of the SMAD family. Defined inter-
vention addressing these signalling modules, alone or in
combination with established therapies targeting TNF
(e.g., etanercept), may therefore improve the efficiency
and outcome of current anti-rheumatic therapy [68].
Alternatively, the present results may be employed to
define subpopulations of RA patients in characteristic
phases of RA (active inflammatory early versus burnt-out/
fibrotic late) and tailor anti-rheumatic treatment to the
particular needs of the respective phase [69].
Both the complexity of even relatively small networks
such as our ECM network and the completeness of the
attribute exploration algorithm led to a large number of
temporal rules. However, high support of a rule (often
correlated to its simplicity) can be used as an indicator for
the most meaningful hypotheses about co-regulation,
mutual exclusion, and/or temporal dependencies not
only between single genes, but between small sets of
(functionally related) genes. The fidelity of our rules was
reinforced by the comparison of simulated and observed
time series data, first manually, then automatically by the
attribute exploration algorithm.
Combining two well-developed algebraic, discrete and
logical methods (Boolean network construction and FCA)
it was possible to include human expert knowledge in all
different phases (assembly of the network, adjustment to
the data, and choice of relevant temporal rules), with the
exception of the challenging data discretisation step. On
the one hand, data discretisation is an important tool to
filter out noise and to reduce complexity, but on the other
hand it inevitably causes loss of information [70]. Care-
fully evaluating the method, we tried to keep as much
important information as possible. In special cases, we
consulted the original data again. A recently developed
FCA-based method avoids predefined discretisation but
computes an ordered set of "interval pattern structures"
depending on the observed values [28]. Thus, a data set
may be described without loss of information or by
means of any desired granularity.
Additional method optimisations comprise strengthening
the expert role on the one hand and up-scaling the net-
work to medium size by supplementary automatisation
on the other. Especially for a small set of interesting genes
an interactive attribute exploration is feasible to fortify the
human expert. Using this procedure for the knowledge
base construction, single rules can be validated manually
or by a supporting computer program, or even new exper-
iments can be suggested. Whereas we applied a strong val-
idation criterion requiring rules to hold for all simulated
and observed transitions, the expert could also reject rules
below a threshold of support and confidence in the
observed context, potentially reducing noise or eliminat-
ing measurement errors.
In order to enhance computational efficiency, methods of
rule selection could be integrated into the algorithm,
based on association rule mining and "iceberg concept
lattices" (by taking advantage of the duality between theBMC Systems Biology 2009, 3:77 http://www.biomedcentral.com/1752-0509/3/77
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stem base and the conceptual hierarchy (lattice) derived
from a transition context as in Table 6) [71]. Manual
adaptation of the network may be replaced by algorithms
of network inference [26].
In summary, the adapted Boolean network model
reported here for the simulation of ECM formation and
degradation in rheumatic diseases may represent a power-
ful tool aiding computational analyses of disease-related
ECM remodelling and supporting a precise design of fur-
ther experiments.
Methods
Clinical data
Patients and samples
Synovial membrane samples were obtained following tis-
sue excision upon joint replacement/synovectomy from
RA and OA patients (n = 3 each; Table 5). Informed
patient consent was obtained and the study was approved
by the ethics committees of the respective university. RA
patients were classified according to the American College
of Rheumatology (ACR) criteria [72], OA patients accord-
ing to the respective criteria for osteoarthritis [73].
The preparation of primary SFB from RA and OA patients
was performed as previously described [65]. Briefly, the
tissue samples were minced and digested with trypsin/col-
lagenase P. The resulting single cell suspension was cul-
tured for seven days. Non-adherent cells were removed by
medium exchange. SFB were then negatively purified
using Dynabeads® M-450 CD14 and subsequently cul-
tured over 4 passages in DMEM containing 100 g/ml
gentamycin, 100 g/ml penicillin/streptomycin, 20 mM
HEPES (all 100 from PAA Laboratories, Coelbe, Ger-
many), and 10% FCS (BioWhittaker-Lonza, Basel, Swit-
zerland).
Cell stimulation and isolation of total RNA
At the end of the fourth passage, the SFB were washed in
serum-free DMEM and then stimulated by 10 ng/ml
TGF1 or TNF (PeproTech, Hamburg, Germany) in
serum-free DMEM for 0, 1, 2, 4, and 12 h. At each time
point, the medium was removed and the cells were har-
vested after treatment with trypsin (0.25% in versene; Inv-
itrogen, Karlsruhe, Germany). After washing with PBS,
they were lysed with RLT buffer (Qiagen, Hilden, Ger-
many) and frozen at -70°C. Total RNA was isolated using
the RNeasy Kit (Qiagen) according to the supplier's rec-
ommendation.
Microarray data analysis
Analysis of gene expression was performed using U133
Plus 2.0 RNA microarrays (Affymetrix®, Santa Clara, CA,
USA). Labelling of RNA probes, hybridisation, and wash-
ing were carried out according to the supplier's instruc-
tions. Microarrays were analysed by laser scanning
(Hewlett-Packard Gene Scanner). Background-corrected
signal intensities were determined and normalised using
the MAS 5.0 software (Affymetrix®). For this purpose,
arrays were grouped according to the respective stimulus
(TGF1 and TNF, n = 6 each). The arrays in each group
were normalised using quantile arrays in normalisation
[74]. Original data from microarray analysis have been
deposited in NCBI Gene Expression Omnibus [42] and
are accessible through GEO series accession number
GSE13837. A list of probe sets and all expression time
courses are provided in additional file 4.
Creating network and Boolean functions
For the selection of genes and proteins involved in ECM
maintenance and for network generation, Boolean que-
ries were performed in PubMed [75]. Articles were
selected containing information about relevant genes
expressed in SFB and involved in ECM maintenance. For
information extraction, the abstracts were screened and
filtered manually for statements on healthy conditions
only. This knowledge-based collection yielded the set of
gene candidates analysed in detail. The final gene list is
presented in Table 1.
The genes were also analysed using Bibliosphere [38] and
literature not extracted from PubMed was added. Subse-
quently, information concerning regulatory relationships
was collected and transformed into short statements serv-
ing as input relations (edges) for the network building
program Cytoscape, version 2.6.0 [76]. Contradictory lit-
erature information was resolved by preferring facts
applying to the target cell type (human fibroblasts) and/
or by comparison with experimental gene expression
results from our and other microarrray data (GSE1742
and GSE2624, see additional file 5). The complete list of
used statements and the respective literature basis can be
found in additional file 1. In a further step, simulation
results were iteratively compared to the experimental data
in the present study, resulting in two adapted Boolean net-
works which represent hypotheses about regulatory proc-
esses initiated by TGF1 and TNF.
Data discretisation
Since we were interested in regulatory interactions, the
fold-change of the expression values was more important
than absolute levels. Hence, we discretised individual
time series separately. The discretised data served to verify
or falsify the temporal dependencies predicted from the
extracted literature knowledge. For that reason, we wanted
to conserve as many effects on gene expression as possible
and set weak criteria for up-regulation: if the highest fold-
change (i.e., the difference of log2 values) between two
arbitrary time points was larger than 1, then the time pro-
file was discretised to 0 or 1 by k-means clustering (100BMC Systems Biology 2009, 3:77 http://www.biomedcentral.com/1752-0509/3/77
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iterations, vote of 25 restarts). We set the constant value 0
if: (i) the highest fold-change between two arbitrary
points in a time series was less than 1; (ii) the absolute
expression value was below the threshold of 100 for one
probe set; or (iii) the Affymetrix detection value p indicat-
ing the reliability of the measurement exceeded 0.05. In
all other cases, the constant was set to 1. Applying these
criteria, also individual values were set to 0 (i.e., off) fol-
lowing clustering.
Principles of simulation
Using the deterministic Boolean network, simulations
were generated using an asynchronous update scheme
based on the subsequent biologically-founded assump-
tions. In order to simulate the time courses more realisti-
cally, transcription and translation were separated, i.e.,
the left side of a Boolean function (output) was consid-
ered as mRNA and the right side as TF and/or stimulus
(input). Unfortunately, time-resolved data for gene
expression events, mRNA, or protein half-life are scarce in
the literature. Therefore, time steps were selected based on
general expert knowledge and comparison of literature
and experimental data, if available. For example, the dura-
tion of transcription was generally set to 1 time unit, for
NF-B it was set to a doubled time period, reflecting its
markedly prolonged response time before expression
compared to the immediate early response transcription
factors AP-1 and ETS1 [77].
In summary, we selected the time steps as follows: tran-
scription 1 (NFKB1: 2), translation: 1, mRNA lifespan: 1,
and protein lifespan: 2. Since TGF1 and TNF have to be
released into the extracellular medium after translation,
they were assumed to take effect three time units after
induction. Nevertheless, we are aware that these intervals
are not absolute durations (e.g., hours), but their qualita-
tive relationships are important. The starting conditions
of the simulations were characterised by the initially
observed, discretised states, and an initial state was intro-
duced, for which the TFs were set to on. Supposing a
steady state situation before starting the stimulation with
TGF1 and TNF, the protein levels at step 0 and 1 were
defined according to that of the corresponding mRNA,
and, in addition, the respective stimulating protein was
set to on. The simulations were performed over twelve
time units, roughly corresponding to the twelve hour
duration of the gene expression experiments.
Creation of a temporal rule knowledge base
For a detailed description of FCA mathematics and strict
definitions see [78]. The sets of observed and simulated
states Sobs and Ssim were characterised by the expression
levels of each gene, i.e., by a subset of attributes M = E ×
F, with entities or genes E, and the corresponding values
F = {off, on}. A state can also be considered as a tuple
(f1, ..., fn) with fi F, n = |E|.
The transitions after one time step define relations Robs
Sobs× Sobs and Rsim Ssim × Ssim on the states. Thus,
in general, multiple output states sout following an input
state sin are possible. However, this case rarely occurred,
justifying the use of a deterministic simulation procedure.
We computed the transitive closure of these relations,
since we were interested in all states emerging from a
given one, within the observation or simulation time. The
data of all time series related to one stimulus was assem-
bled in the "formal contexts" Kobs and Ksim which repre-
sent the basic data structure of FCA. These define relations
I between objects (the transitions) and attributes (the dis-
cretised gene expression levels in input and output states).
Accordingly, the rows in Table 6 represent transitions,
expressed as tuples of input and output attributes (f1
in,
..., fn
in, f1
out, ..., fn
out).
Generally, we applied the interactive version of the
attribute exploration algorithm [54] to Ksim. It generates a
minimal set of implications: A  B, A, B  M ×
{in, out}, which are valid in the formal context Ksim.
An implication means that if any transition has all
attributes a  A, then it also has all attributes b  B. An
expert (or, alternatively, a computer programme) is asked
to validate each implication. If s/he denies, a counter-
example must be provided, i.e., a new transition of the
context. If s/he accepts, the implication is added to the
"stem base" of the context.
As a result, a sound, complete, and non-redundant knowl-
edge base is created, from which all implications, valid
according to the semantics given by the enlarged formal
context Ksim, can be derived. In other words, the implica-
tions are valid regarding the knowledge formalised in the
Boolean network and can also be checked by supplemen-
tary human expert knowledge or further literature
research, e.g., for co-regulation of genes or possible or for-
bidden resulting states.
In this study, we compared the literature-based implica-
tions with those merely derived from the data and applied
a strong criterion: implications of Ksim had to be valid for
all transitions of the observed context Kobs. This is equiv-
alent to an exploration of the union of the two contexts,
where every proposed implication is accepted. Thus, the
resulting stem base was computed automatically with the
Java tool Concept Explorer which supports also expert
centred attribute exploration [79]. The other calculations
were made with our own R [http://www.r-project.org]
programs (available upon request).BMC Systems Biology 2009, 3:77 http://www.biomedcentral.com/1752-0509/3/77
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In the worst case, the running time of the attribute explo-
ration algorithm depends exponentially on the size of the
input data table (rows × columns) [80]. Computing the
2,713 (8,785) TGF1 (TNF) rules, Concept Explorer ran
21 (30) minutes on a 2.66 GHz/2 GB computer.
Expert analysis of transition rules
The calculated transition rules were screened manually,
focussing on the appearance and the temporal behaviour
of the following features: (i) constitutive vs. induced gene
expression; (ii) co-expression vs. divergent expression of
mediators, TFs, and target genes; (iii) expression of medi-
ators/transcription factors vs. expression of target genes;
(iv) regulation of target gene expression based on the
expression of different transcription factors; (v) expres-
sion of individual genes vs. expression of their functional
groups; and (vi) discrepancies to the literature. Subse-
quently, the extracted rules were assessed with respect to
biological coherence and relevance.
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